Healthcare & Life Sciences

myNEO Therapeutics

myNEO Therapeutics is a startup based in Belgium, most recent round Series A, 2 tracked investors.

activeseries-a
series-a
Stage
2
Investors

About myNEO Therapeutics

myNEO Therapeutics is a company headquartered in Belgium. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.

myNEO Therapeutics leverages its ImmunoEngine platform to tap into novel promising tumor targets found in the dark genome – named camyotopes™ – which have the potential to unlock immunotherapy for large patient populations who currently do not respond.

Explore myNEO Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Belgium